SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-001856
Filing Date
2024-02-15
Accepted
2024-02-15 16:45:37
Documents
16
Period of Report
2024-02-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zivo_8k.htm   iXBRL 8-K 23959
  Complete submission text file 0001654954-24-001856.txt   143692

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zivo-20240213.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20240213_lab.xml EX-101.LAB 14146
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20240213_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20240213_pre.xml EX-101.PRE 8922
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20240213_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8k_htm.xml XML 3795
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40449 | Film No.: 24644482
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)